62 related articles for article (PubMed ID: 7835164)
21. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
22. Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue.
Johnsson A; Kjellén E; Wennerberg J; Pero R
Anticancer Drugs; 1996 Jun; 7(4):483-8. PubMed ID: 8826617
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
24. Detection of mitomycin C-DNA adducts in human breast cancer cells grown in culture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by (32)P-postlabeling.
Warren AJ; Mustra DJ; Hamilton JW
Clin Cancer Res; 2001 Apr; 7(4):1033-42. PubMed ID: 11309355
[TBL] [Abstract][Full Text] [Related]
25. [Inhibition effect on Tca8113/CDDP by antisense oligonucleotides of cyclin D1 combined with cis diamminedichloroplatinum].
Zhou XJ; Yu Y; Pan HY; Chen WT; Zhang P; Zhang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):354-7. PubMed ID: 16836906
[TBL] [Abstract][Full Text] [Related]
26. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
27. [Dual biochemical modulation therapy using 5-FU, leucovorin and cisplatin on human rectal carcinoma xenografts in nude mouse].
Shibusawa M; Takata M; Kamiyama G; Yokoyama N; Nakao K; Yoshizawa H; Choh H; Yasuda N; Tsunoda Y; Tsunoda A; Kusano M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1149-52. PubMed ID: 8751802
[TBL] [Abstract][Full Text] [Related]
28. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
[TBL] [Abstract][Full Text] [Related]
29. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers.
Hsu TM; Zhang YJ; Santella RM
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):193-9. PubMed ID: 9138663
[TBL] [Abstract][Full Text] [Related]
30. [Antitumor effect of S-1 and cisplatin treatment against human gastric cancer xenografted in nude mice].
Kondo K; Akiyama S; Kasai Y; Kato S; Kuno Y; Kataoka M; Ichihara T; Horisawa M; Shirasaka T
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1103-8. PubMed ID: 9239163
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect of silencing hTERT gene by short hairpin RNA on growth of human laryngeal squamous cell carcinoma xenograft in nude mice].
Liu D; Tao ZZ; Xiao BK; Chen SM; Chi HM
Ai Zheng; 2006 Jan; 25(1):11-6. PubMed ID: 16405742
[TBL] [Abstract][Full Text] [Related]
32. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin-DNA adduct determination in the hepatic albumin gene as compared to whole genomic DNA.
Zhang Z; Poirier MC
Chem Res Toxicol; 1997 Sep; 10(9):971-7. PubMed ID: 9305578
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effect of CDDP and VP-16 against human bladder cancers.
Gotoh A; Mizuno Y; Okada H; Arakawa S; Kitazawa S; Maeda S; Kamidono S
In Vivo; 1995; 9(3):263-7. PubMed ID: 8562894
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
Meijer C; de Vries EG; Marmiroli P; Tredici G; Frattola L; Cavaletti G
Neurotoxicology; 1999 Dec; 20(6):883-7. PubMed ID: 10693969
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of the anticancer agent cisplatin in the treatment of human cervical squamous carcinoma xenografted in nude mice.
Pillay CV; Green-Thompson R; Brock-Utne JG
Chemotherapy; 1986; 32(4):356-63. PubMed ID: 3731921
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of CDDP on human rhabdomyosarcoma transplanted in nude mice.
Masuda S; Shinohara N; Chuman H
Fukuoka Igaku Zasshi; 1982 Sep; 73(9):541-7. PubMed ID: 6891367
[No Abstract] [Full Text] [Related]
38. Amifostine as a protector against cisplatin-induced toxicity in nude mice.
Johnsson A; Wennerberg J
Acta Oncol; 1999; 38(2):247-53. PubMed ID: 10227448
[TBL] [Abstract][Full Text] [Related]
39. Visualization and Quantitative Measurement of Drug-Induced Platinum Adducts in the Nuclear DNA of Individual Cells by an Immuno-Cytological Assay.
Melnikova M; Thomale J
Methods Mol Biol; 2018; 1655():351-358. PubMed ID: 28889396
[TBL] [Abstract][Full Text] [Related]
40. Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.
Hanada K; Nagai N; Ogata H
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):181-6. PubMed ID: 7704209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
